Ingevity Corp buy BMO Capital Markets
Start price
10.12.25
/
50%
€46.50
Target price
10.12.26
€60.10
Performance (%)
8.39%
Price
09.01.26
€54.25
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 8.39%. This prediction currently runs until 10.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Ingevity Corp | 6.164% |
| iShares Core DAX® | 3.002% |
| iShares Nasdaq 100 | 2.966% |
| iShares Nikkei 225® | 5.606% |
| iShares S&P 500 | 2.312% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $64.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat